S De Vleeschouwer - 2017 - pubmed.ncbi.nlm.nih.gov
Glioblastoma is the commonest and the most lethal brain tumor. In this book 71 experts from around the globe come together to give a timely, unique and exhaustive compilation of …
H Slika, Z Karimov, P Alimonti, T Abou-Mrad… - International journal of …, 2023 - mdpi.com
Glioblastoma is the most common malignant primary central nervous system tumor and one of the most debilitating cancers. The prognosis of patients with glioblastoma remains poor …
P Liu, S Griffiths, D Veljanoski… - Expert Reviews in …, 2021 - cambridge.org
Glioblastoma (GBM) is the most common and aggressive primary brain tumour, yet little progress has been made towards providing better treatment options for patients diagnosed …
C Boccellato, M Rehm - Cellular Oncology, 2022 - Springer
Background Glioblastoma (GBM) patients are notoriously difficult to treat and ultimately all succumb to disease. This unfortunate scenario motivates research into better characterizing …
M Karakaya, PO Yerlikaya - Biotech Studies - dergipark.org.tr
Glioblastoma is a highly malignant brain tumor classified as grade IV with a poor prognosis and approximately a year of survival rate. The molecular changes that trigger primary …
AG Bhargav, JS Domino, AM Alvarado… - Frontiers in …, 2023 - frontiersin.org
Gliomas are the most common primary brain tumors in adults and carry a dismal prognosis for patients. Current standard-of-care for gliomas is comprised of maximal safe surgical …
S Barachini, M Morelli… - Current Opinion in …, 2023 - journals.lww.com
By utilizing a combination of these preclinical models and fostering interdisciplinary collaborations, researchers can deepen their understanding of glioma brain tumors and …
L Janbazian, J Karamchandani, S Das - Journal of Neuro-Oncology, 2014 - Springer
Glioblastoma is the most common primary brain tumour in adults. While many patients achieve disease remission following treatment with surgical resection, radiation therapy and …
Glioblastoma multiforme (GBM) is one of the deadliest human cancers. Despite increasing knowledge of the genetic and epigenetic changes that underlie tumour initiation and growth …